CONFERENCE PROCEEDING
Useful biological markers in COPD smoking
patients
More details
Hide details
1
'Grigore T. Popa' University of Medicine and Pharmacy, Iași, Romania
2
Faculy of Medicine, 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania
3
Clinical Hospital of Pulmonary Diseases, Iași, Romania
Publication date: 2022-07-05
Tob. Prev. Cessation 2022;8(Supplement):A103
ABSTRACT
Background:
Smoking is the most incriminated and studied risk factor for
COPD, but other factors like air pollution are also linked to this
disease. Assessment of nicotine dependence may be performed
clinically or paraclinical.
Objective:
To assess useful biological markers in COPD smoking patients.
Methods:
In this observational study, 52 patients diagnosed with different
stages of COPD were included and clinical features and biological
variables were statistically assessed. The biological markers
measured were ALAT-alanine amino aminotransferase, ASAT
- aspartate aminotransferase, urea, creatinine, total cholesterol,
triglycerides, high density lipoprotein cholesterol (HDL-CHOL),
low density lipoproteins-cholesterol (LDL-CHOL), lactate
dehydrogenase (LDH), and uric acid.
Results:
Significant correlations were obtained between COPD stages
and serum uric acid concentrations (r=0.4; p<0.05), smoking
status (smoker/non-smoker/ex-smoker) and total serum
cholesterol values (r=0.45; p<0.05), but also between serum
urea concentrations and the number of pack-years for the
smoker/ex-smoker groups (r=0.45; p<0.05). The statistical
difference between the investigated smoker/non-smoker/exsmoker
groups was assessed with the Man-Whitney U test.
Thus, the statistical results showed a statistically significant
difference between the smoker/ex-smoker groups given by the
following biological variables: total cholesterol (p=0.012),
LDL-CHOL (p=0.039), PY-pack-years (p=0.006). The results
from the descriptive statistics point to LDL-CHOL values for
smokers and ex-smokers of 106.34 mg/dL and 110.53 mg/dL,
respectively, slightly higher than the reference biological range
compared to the mean LDL-CHOL concentration values in nonsmokers
(98.28 mg/dL).
Conclusions:
The results show that lipid metabolism seems to be affected by
smoking and other studies conducted in this field also show a
correlation between this habit and high levels of triglycerides
and low levels of HDL cholesterol. Uric acid can be used as a
biomarker of exposure to tobacco smoke.